相关实验视频

Updated: May 1, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo

Published on: August 4, 2018

提升脂肪吸的安全性和有效性:通过基于的等离子体集成进行外科医生学习曲线分析

Paul G Ruff, Allison Martinez, Nicholas Burpee

Aesthetic surgery journal. Open forum

|October 18, 2024

概括

这项研究发现,使用基于的血装置与脂肪吸改善了患者的治疗结果和安全性. 主要研究人员的持续使用表明了学习曲线效应,没有报告严重不良事件.

科学领域:

审美医学是一种美学医学.
最少侵入性手术的方法
基于能源的设备

背景情况:

对医学进步的批判性评估对于改善患者的治疗结果和安全至关重要.
最少侵入性,以能量为基础的设备越来越多地用于美容医学.
对新技术的持续评估对于完善临床实践至关重要.

研究的目的:

评估对抽脂手术的回顾性数据.
评估基于的等离子体装置的安全性和结果.
为了比较三个治疗组,并勾勒出学习曲线.

主要方法:

150名健康患者 (≥18岁) 的回顾性图表审查.
三组:超声波辅助脂肪吸,基于的血装置的脂肪吸,以及最近使用基于的血装置的脂肪吸.
对所有患者进行至少6个月的术后随访.

主要成果:

招募了150名患者,主要在部和腹部接受治疗.
在疼痛和治疗组之间发现了显著的关系 (P = .013).
没有发生严重或意想不到的不良事件 (AE);所有问题都通过随访得到解决.

结论:

主要研究人员继续使用基于的血装置与改善患者的治疗结果和安全性有关.
这种基于的血装置可以安全地与抽脂程序结合使用.
数据支持辅助基血装置在抽脂中的疗效和安全性.

更多相关视频

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

Mechanical Micronization of Lipoaspirates for Regenerative Therapy

Mechanical Micronization of Lipoaspirates for Regenerative Therapy

Published on: March 15, 2019

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...